tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Zymeworks: Hold Rating Amid Uncertain Market Potential and Upcoming Catalysts
PremiumRatingsZymeworks: Hold Rating Amid Uncertain Market Potential and Upcoming Catalysts
1M ago
Zymeworks Gains Momentum with European Approval and Promising Financial Milestones for Zanidatamab
Premium
Ratings
Zymeworks Gains Momentum with European Approval and Promising Financial Milestones for Zanidatamab
1M ago
Zymeworks Amends Warrant Agreement with EcoR1 Capital
Premium
Company Announcements
Zymeworks Amends Warrant Agreement with EcoR1 Capital
1M ago
Zymeworks’ Zanidatamab Receives NMPA Approval in China for HER2+ Biliary Tract Cancer
PremiumCompany AnnouncementsZymeworks’ Zanidatamab Receives NMPA Approval in China for HER2+ Biliary Tract Cancer
2M ago
Zymeworks announces NMPA approval of zanidatamab in China
Premium
The Fly
Zymeworks announces NMPA approval of zanidatamab in China
2M ago
Zymeworks Showcases Oncology Advances at Major Conferences
Premium
Company Announcements
Zymeworks Showcases Oncology Advances at Major Conferences
2M ago
Zymeworks initiated with a Buy at TD Cowen
PremiumThe FlyZymeworks initiated with a Buy at TD Cowen
3M ago
Zymeworks Unveils Promising Preclinical Data for Novel Respiratory Treatment
Premium
Company Announcements
Zymeworks Unveils Promising Preclinical Data for Novel Respiratory Treatment
3M ago
Zymeworks presents new ZW1528 data at ATS conference
Premium
The Fly
Zymeworks presents new ZW1528 data at ATS conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100